Is BARD1 p.Glu19= (c.57G>A) pathogenic?

BARD1 p.Glu19= (c.57G>A) is classified Benign/Likely benign in BARD1 (ClinVar, Multiple submitters, 12 submitters; last evaluated 2025-12-29). Very rare (popmax 0.00349%, nfe); Associated with hereditary neoplastic syndrome.

What condition is associated with BARD1 p.Glu19= (c.57G>A)?

BARD1 p.Glu19= (c.57G>A) is associated with hereditary neoplastic syndrome, hereditary breast carcinoma (ClinVar).

How common is BARD1 p.Glu19= (c.57G>A) in the general population?

BARD1 p.Glu19= (c.57G>A) is very rare (popmax 0.00349%, nfe) (gnomAD).

BARD1 p.Glu19=

c.57G>A · rs730881406 · VCV182029

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 12 submitters

gnomAD v4.1

Rare

very rare (popmax 0.00349%, nfe)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 1.5	GERP -0.028, phastCons 1
Overall
CADD	10.37	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00349% European (non-Finnish) · 41/1,174,560 alleles

Filtering AF 0.0026% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00234%

Overall 0.00275% 44/1,598,678 alleles · very rare

Ancestry group	Frequency	1 in
European (non-Finnish)grpmax	0.00349%	28,648
Remaining individualsnot grpmax-eligible	0.00323%	30,950
African / African-American	0.00134%	74,602

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: BARD1
Protein: p.Glu19=
Coding: c.57G>A
MANE Select: NM_000465
dbSNP: rs730881406
Type: single nucleotide variant
Location: chr2:214809513 (GRCh38)
Gene constraint: LOEUF 1.087 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 64.82 · 11 PDB
Residue 19: the 'disordered' region

Full BARD1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary breast carcinoma

Similar variants

BARD1 p.Glu19Ter Pathogenic/Likely pathogenic ★★ same residue
BARD1 p.Glu19Asp Uncertain significance ★★ ⚠ same residue
BARD1 p.Glu19Lys Uncertain significance ★★ ⚠ same residue
BARD1 p.Glu19Gln Uncertain significance ★ ⚠ same residue
BARD1 c.1314+1G>A Pathogenic/Likely pathogenic ★★ same condition
BARD1 c.1314+1G>T Likely pathogenic ★★ same condition
BARD1 c.1396-1G>A Likely pathogenic ★★ same condition
BARD1 c.1396-1G>C Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bard1-p-glu19 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown